Myogenic Potential of Whole Bone Marrow Mesenchymal Stem Cells In Vitro and In Vivo for Usage in Urinary Incontinence

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Gunetti, Monica ^a   Tomasi, Simone ^b   Giammò, Alessandro ^c   Boido, Marina ^b   Rustichelli, Deborah ^a   Mareschi, Katia ^a,b   Errichiello, Edoardo ^a   Parola, Maurizio ^b   Ferrero, Ivana ^a,b   Fagioli, Franca ^a   Vercelli, Alessandro ^b   Carone, Roberto ^c  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CTO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CALCIUM CHANNEL L TYPE; DESMIN; MYOGENIN; MYOSIN; SARCOMERIC ACTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER SPHINCTER; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOTUBE; NERVE ENDING; NONHUMAN; PELVIS FLOOR; PHENOTYPE; PROTEIN EXPRESSION; RAT; URINE INCONTINENCE; XENOTRANSPLANTATION;

ANIMALS; BONE MARROW CELLS; CALCIUM CHANNELS, L-TYPE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; HUMANS; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; RATS; TISSUE THERAPY; URINARY INCONTINENCE;

EID: 84866695158     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045538     Document Type: Article

References (55)

1. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, et al. (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21: 5-26.
2. Strasser H, Tiefenthaler M, Steinlechner M, Eder I, Bartsch G, et al. (2000) Age dependent apoptosis and loss of rhabdosphincter cells. The Journal of Urology 164: 1781-1785.
3. Nikolavsky D, Chancellor MB, (2010) Stem cell therapy for stress urinary incontinence. Neurourol Urodyn 29Suppl 1: S36-41.
4. Corcos J, Loutochin O, Campeau L, Eliopoulos N, Bouchentouf M, et al. (2010) Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence. Neurourology and urodynamics 30: 447-455.
5. Sweat SD, Lightner DJ, (1999) Complications of sterile abscess formation and pulmonary embolismfollowing periurethral bulking agents. J Urol 161: 93-96.
6. Appell RA, Dmochowski RR, Herschorn S, (2006) Urethral injections for female stress incontinence. BJU Int 98: 27-30.
7. Heidler S, (2011) Female incontinence: long-term results of slings. Curr Opin Urol 21: 488-492.
8. Hübner WA, Schlarp OM, (2005) Treatment of incontinence after prostatectomy using a new minimally invasive device: adjustable continence therapy. BJU Int 96: 587-594.
9. Deng DY, Rutman M, Raz S, Rodriguez LV, (2007) Presentation and management of major complications of midurethral slings: Are complications under-reported? Neurourol Urodyn 26: 46-52.
10. DeLancey JO, Trowbridge ER, Miller JM, Morgan DM, Guire K, et al. (2008) Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol 179: 2286-2290.
11. Sherman LS, Munoz J, Patel SA, Dave MA, Paige I, et al. (2011) Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells. Clin Transl Sci 4: 380-386.
12. Shokeir AA, Harraz AM, El-Din AB, (2010) Tissue engineering and stem cells: basic principles and applications in urology. Int J Urol 17: 964-973.
13. Mitterberger M, Marksteiner R, Margreiter E, Pinggera GM, Frauscher F, et al. (2008) Myoblast and fibroblast therapy for post-prostatectomy urinary incontinence: 1-year followup of 63 patients. The Journal of Urology 179: 226-231.
14. Ding DC, Shyu WC, Lin SZ, (2011) Mesenchymal stem cells. Cell Transplant 20: 5-14.
15. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, et al. (2006) Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97: 744-754.
16. Mareschi K, Rustichelli D, Comunanza V, De Fazio R, Cravero C, et al. (2009) Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels. Cytotherapy 11: 534-547.
17. Burdon TJ, Paul A, Noiseux N, Prakash S, Shum-Tim D, (2011) Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative Medicine: Current Perspectives and Therapeutic Potential. Bone Marrow Research 2011: 1-14.
18. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, et al. (2006) Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res 28: 523-526.
19. Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, et al. (2008) Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease 31: 395-405.
20. Boido M, Rupa R, Garbossa D, Fontanella M, Ducati A, et al. (2009) Embryonic and adult stem cells promote raphespinal axon outgrowth and improve functional outcome following spinal hemisection in mice. Eur J Neurosci 30: 833-846.
21. Garbossa D, Boido M, Fontanella M, Fronda C, Ducati A, et al. (2012) Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells. Neurosurg Rev 35: 293-311.
22. Yaffe D, Saxel O, (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
23. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y, (1997) 'Green mice' as a source of ubiquitous green cells. FEBS Lett 407: 313-319.
24. Lee JH, Kosinski PA, Kemp DM, (2005) Contribution of human bone marrow stem cells to individual skeletal myotubes followed by myogenic gene activation. Exp Cell Res 307: 174-182.
25. Carvalho KA, Guarita-Souza LC, Hansen P, Rebelatto CL, Senegaglia AC, et al. (2006) Cell transplantation after the coculture of skeletal myoblasts and mesenchymal stem cells in the regeneration of the myocardium scar: an experimental study in rats. Transplant Proc 38: 1596-1602.
26. Carvalho KA, Guarita-Souza LC, Rebelatto CL, Senegaglia AC, Hansen P, et al. (2004) Could the coculture of skeletal myoblasts and mesenchymal stem cells be a solution for postinfarction myocardial scar? Transplant Proc 36: 991-992.
27. Beier JP, Bitto FF, Lange C, Klumpp D, Arkudas A, et al. (2011) Myogenic differentiation of mesenchymal stem cells co-cultured with primary myoblasts. Cell Biol Int 35: 397-406.
28. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
29. Mareschi K, Rustichelli D, Calabrese R, Gunetti M, Sanavio F, et al. (2012) Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use. Stem Cell Int 2012: 920581 doi: 10.1155/2012/920581. Available: www.hindawi.com/journals/sci/2012/9205817. Accessed 2011 Oct 15.
30. Gawronska-Kozak B, Manuel JA, Prpic V, (2007) Ear mesenchymal stem cells (EMSC) can differentiate into spontaneously contracting muscle cells. Journal of Cellular Biochemistry 102: 122-135.
31. Barry EL, (2000) Expression of mRNAs for the alpha 1 subunit of voltage-gated calcium channels in human osteoblast-like cell lines and in normal human osteoblasts. Calcified tissue international 66: 145-150.
32. Li H, Capetanaki Y, (1993) Regulation of the mouse desmin gene: transactivated by MyoD, myogenin, MRF4 and Myf5. Nucleic Acids Res. 21: 335-343.
33. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
34. Wakitani S, Saito T, Caplan AI, (1995) Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18: 1417-1426.
35. Drost AC, Weng S, Feil G, Schäfer J, Baumann S, et al. (2009) In vitro Myogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells as a Potential Treatment for Urethral Sphincter Muscle Repair. Annals of the New York Academy of Sciences 1176: 135-143.
36. Karaoz E, Okcu A, Gacar G, Saglam O, Yuruker S, et al. (2011) A comprehensive characterization study of human bone marrow mscs with an emphasis on molecular and ultrastructural properties. J Cell Physiol 226: 1367-1382.
37. Kolf CM, Cho E, Tuan RS, (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9: 204.
38. Case R, Eisner D, Gurney A, Jones O, Muallem S, et al. (2007) Evolution of calcium homeostasis: From birth of the first cell to an omnipresent signalling system. Cell Calcium 42: 345-350.
39. Clapham DE, (2007) Calcium Signaling. Cell 131: 1047-1058.
40. Ye B, (2010) Ca2+ oscillations and its transporters in mesenchymal stem cells. Physiol Res 59: 323-329.
41. Kawano S, Otsu K, Shoji S, Yamagata K, Hiraoka M, (2003) Ca(2+) oscillations regulated by Na(+)-Ca(2+) exchanger and plasma membrane Ca(2+) pump induce fluctuations of membrane currents and potentials in human mesenchymal stem cells. Cell Calcium 34: 145-156.
42. Li GR, Sun H, Deng X, Lau CP, (2005) Characterization of ionic currents in human mesenchymal stem cells from bone marrow. Stem Cells 23: 371-382.
43. Heubach JF, Graf EM, Leutheuser J, Bock M, Balana B, et al. (2004) Electrophysiological properties of human mesenchymal stem cells. The Journal of physiology 554: 659-672.
44. Resende RR, Adhikari A, da Costa JL, Lorençon E, Ladeira MS, et al. (2010) Influence of spontaneous calcium events on cell-cycle progression in embryonal carcinoma and adult stem cells. Biochim Biophys Acta 1803(2): 246-260.
45. Shabbir A, Zisa D, Leiker M, Johnston C, Lin H, et al. (2009) Muscular dystrophy therapy by nonautologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammation. Transplantation 87: 1275-1282.
46. Aggarwal S, Pittenger MF, (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822.
47. Liu L, Sun Z, Chen B, Han Q, Liao L, et al. (2006) Ex vivo expansion and in vivo infusion of bone marrow derived Flk-1_CD31_CD34_ mesenchymal stem cells: feasibility and safety from monkey to human. Stem Cells Dev 15: 349-357.
48. Caplan AI, (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217: 318-324.
49. Canzi L, Castellaneta V, Navone S, Nava S, Dossena M, et al. (2011) Human Skeletal Muscle Stem Cells' Anti-inflammatory Activity Ameliorate Clinical Outcome in Amyotrophic Lateral Sclerosis Model. Mol Med. 2012 18: 401-411 doi: 10.2119/molmed.2011.00123. Available: http://www.molmed.org/pdfstore/11_123_Canzi.pdf. Accessed 2011 Nov 4.
50. Hanada M, Sumino Y, Hirata Y, Sato F, Mimata H, (2010) Growth inhibition and apoptosis induction by tumor necrosis factor-alpha in human urethral rhabdosphincter satellite cells. J Urol 183: 2445-2450.
51. Yamamoto T, Gotoh M, Hattori R, Toriyama K, Kamei Y, et al. (2010) Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases. Int J Urol 17: 75-82.
52. Lee PE, Kung RC, Drutz HP, (2001) Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol 165: 153-158.
53. Lin G, Wang G, Banie L, Ning H, Shindel AW, et al. (2010) Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy 12: 88-95.
54. Kinebuchi Y, Aizawa N, Imamura T, Ishizuka O, Igawa Y, et al. (2010) Autologous bone-marrow-derived mesenchymal stem cell transplantation into injured rat urethral sphincter. Int J Urol 17: 359-368.
55. Zhao W, Zhang C, Jin C, Zhang Z, Kong D, et al. (2011) Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model. European urology 59: 155-163.